Charmacy Pharmaceutical Co Ltd
HKEX:2289
Charmacy Pharmaceutical Co Ltd
Operating Income
Charmacy Pharmaceutical Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Charmacy Pharmaceutical Co Ltd
HKEX:2289
|
Operating Income
¥107.5m
|
CAGR 3-Years
11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
Sinopharm Group Co Ltd
HKEX:1099
|
Operating Income
¥22.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Operating Income
¥8.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Operating Income
¥4.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Operating Income
¥2.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
5%
|
CAGR 10-Years
20%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Operating Income
¥3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
See Also
What is Charmacy Pharmaceutical Co Ltd's Operating Income?
Operating Income
107.5m
CNY
Based on the financial report for Dec 31, 2023, Charmacy Pharmaceutical Co Ltd's Operating Income amounts to 107.5m CNY.
What is Charmacy Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
4%
Over the last year, the Operating Income growth was 19%. The average annual Operating Income growth rates for Charmacy Pharmaceutical Co Ltd have been 11% over the past three years , 4% over the past five years .